Avalo Therapeutics Free Cash Flow (Quarterly) Analysis

Avalo Therapeutics Inc (AVTX)

12.00 -1.63 (-11.96%) USD | NASDAQ | Apr 18, 16:00

12.00 0.00 (0.00%) After-Hours: 19:23

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-2.766M
September 30, 2023	-6.836M
June 30, 2023	-10.87M
March 31, 2023	-10.21M
December 31, 2022	-3.94M
September 30, 2022	5.687M
June 30, 2022	-12.53M
March 31, 2022	-16.07M
December 31, 2021	-17.11M
September 30, 2021	-16.37M
June 30, 2021	-19.19M
March 31, 2021	-18.34M
December 31, 2020	-14.38M
September 30, 2020	-11.93M
June 30, 2020	-8.555M
March 31, 2020	-5.739M
December 31, 2019	-1.680M
September 30, 2019	-7.620M
June 30, 2019	-6.808M
March 31, 2019	-3.288M

Date	Value
December 31, 2018	-2.475M
September 30, 2018	-0.5775M
June 30, 2018	-0.3404M
March 31, 2018	-0.2996M
December 31, 2017	-2.564M
September 30, 2017	19.12M
June 30, 2017	-1.759M
March 31, 2017	-2.238M
December 31, 2016	-3.722M
September 30, 2016	-3.440M
June 30, 2016	-3.730M
March 31, 2016	-3.716M
December 31, 2015	-3.548M
September 30, 2015	-1.835M
June 30, 2015	-1.731M
March 31, 2015	-3.069M
December 31, 2014	-3.968M
September 30, 2014	-7.120M
June 30, 2014	-2.238M
March 31, 2014	-2.212M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-19.19M

Minimum

Jun 2021

5.687M

Maximum

Sep 2022

-9.750M

Average

-10.21M

Median

Mar 2023

Free Cash Flow (Quarterly) Benchmarks